Of the 147 non-angiocentric gliomas analyzed by WGS or RNA-seq, none exhibited MYB-QKI fusions, suggesting that this fusion might be a specific target for AG (Bandopadhayay et al., 2016) (Table 1). This evidence concerns the gene MYB and central nervous system cancer.